NCT02419664 2022-03-31Ga-68-DOTATOC -PET in the Management of Pituitary TumoursGöteborg UniversityPhase 3 Terminated22 enrolled
NCT00936741 2014-04-02An Extension Study of CORLUX in the Treatment of Endogenous Cushing's SyndromeCorcept TherapeuticsPhase 3 Completed30 enrolled 8 charts
NCT01371565 2014-03-18Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's SyndromeCorcept TherapeuticsPhase 3 Completed4 enrolled 7 charts